The 2017 conference will gather physicians and researchers of all imaging modalities (PET, MRI, SPECT) under the auspices of the European Association of Nuclear Medicine (EANM). 
This conference will be an opportunity to review some of the major aspects of neuroimaging in neurology and psychiatry while studying new research perspectives in these fields.
It will focus on MRI, PET  imaging, as well as new imaging modalities such as PET/MR, Alzheimer’s Disease, Parkinson's Disease, ALS, Neuroinflammation, tau imaging and other brain diseases. 

An Educational Course on Translating Research into Drugs

This didactic conference will educate scientists on the processes of translating basic research into novel therapies and will leave participants with a strong knowledge base and relevant resources to address the associated barriers and challenges in developing a drug.

The programs will also highlight case studies of small molecule and biologics programs at different stages of development aimed at tackling challenging CNS targets relevant to neurodegenerative diseases.

This course provides an overview of the molecular basis of neurodegeneration and the development of treatment strategies to combat neurodegenerative disorders. The programme will focus on several disorders including Alzheimer’s disease, Parkinson’s disease, Fragile X, Spinocerebellar ataxia and amyotrophic lateral sclerosis. There are many parallels between different neurodegenerative disorders and the course will examine the common themes across neurodegenerative processes.